Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- 2 Classification of Dystonia
- 3 Primary or Idiopathic Dystonias (‘Isolated Dystonia’)
- 4 Non-Primary Dystonias
- 5 Epidemiology of Dystonia
- 6 The Motor Network Model for Dystonia
- 7 Functional Imaging in Dystonia
- 8 The Pathophysiology of Dystonia
- 9 Animal Models of Dystonia
- 10 Genetics of the Dystonias
- 11 Dystonia
- 12 Dystonia and Tremor
- 13 Posttraumatic Dystonia
- 14 Non-Motor Symptoms in Dystonia
- 15 Scales for Assessment of Dystonia
- 16 Theories Behind Dystonia Scale Development
- 17 Linking Allied Health Professionals and Physicians
- 18 The Role and Responsibility of the Dystonia Specialist Nurse
- 19 History of Dystonia Treatments
- 20 Dystonia in Arts and Artists
- Section II Botulinum Toxin Therapy
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
9 - Animal Models of Dystonia
from Section I - Basics
Published online by Cambridge University Press: 31 May 2018
Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- 2 Classification of Dystonia
- 3 Primary or Idiopathic Dystonias (‘Isolated Dystonia’)
- 4 Non-Primary Dystonias
- 5 Epidemiology of Dystonia
- 6 The Motor Network Model for Dystonia
- 7 Functional Imaging in Dystonia
- 8 The Pathophysiology of Dystonia
- 9 Animal Models of Dystonia
- 10 Genetics of the Dystonias
- 11 Dystonia
- 12 Dystonia and Tremor
- 13 Posttraumatic Dystonia
- 14 Non-Motor Symptoms in Dystonia
- 15 Scales for Assessment of Dystonia
- 16 Theories Behind Dystonia Scale Development
- 17 Linking Allied Health Professionals and Physicians
- 18 The Role and Responsibility of the Dystonia Specialist Nurse
- 19 History of Dystonia Treatments
- 20 Dystonia in Arts and Artists
- Section II Botulinum Toxin Therapy
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Treatment of Dystonia , pp. 49 - 52Publisher: Cambridge University PressPrint publication year: 2018
References
Albanese, A, Bhatia, K, Bressman, SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013; 28: 863–873.CrossRefGoogle ScholarPubMed
Balcioglu, A, Kim, MO, Sharma, N, et al. Dopamine release is impaired in a mouse model of DYT1 dystonia. J Neurochem 2007; 102: 783–788.CrossRefGoogle Scholar
Breakefield, XO, Blood, AJ, Li, Y, et al. The pathophysiological basis of dystonias. Nat Rev Neurosci 2008; 9: 222–234.CrossRefGoogle ScholarPubMed
Chen, P, Burdette, AJ, Porter, JC, et al. The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response. Hum Mol Genet 2010; 19: 3502–3515.CrossRefGoogle ScholarPubMed
Dang, MT, Yokoi, F, McNaught, KS, et al. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol 2005; 196: 452–463.CrossRefGoogle Scholar
DeAndrade, MP, Yokoi, F, van Groen, T, et al. Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav Brain Res 2011; 216: 659–665.CrossRefGoogle Scholar
Goodchild, RE, Kim, CE, Dauer, WT. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005; 48: 923–932.CrossRefGoogle ScholarPubMed
Grundmann, K, Reischmann, B, Vanhoutte, G, et al. Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol Dis 2007; 27: 190–206.CrossRefGoogle Scholar
Grundmann, K, Glöckle, N, Martella, G, et al. Generation of a novel rodent model for DYT1 dystonia. Neurobiol Dis 2012; 47: 61–74.CrossRefGoogle ScholarPubMed
Martella, G, Tassone, A, Sciamanna, G, et al. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 2009; 132: 2336–2349.CrossRefGoogle ScholarPubMed
Martella, G, Maltese, M, Nisticò, R, et al. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia. Neurobiol Dis 2014; 65: 124–132.CrossRefGoogle Scholar
Muraro, NI, Moffat, KG. Down-regulation of torp4a, encoding the Drosophila homologue of torsinA, results in increased neuronal degeneration. J Neurobiol 2006; 66: 1338–1353.CrossRefGoogle ScholarPubMed
Page, ME, Bao, L, Andre, P, et al. Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice. Neurobiol Dis 2010; 39: 318–326.CrossRefGoogle ScholarPubMed
Pisani, A, Bernardi, G, Ding, J, et al. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 2007; 30: 545–553.CrossRefGoogle ScholarPubMed
Sato, K, Sumi-Ichinose, C, Kaji, R, et al. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci USA 2008; 105: 12551–12556.CrossRefGoogle Scholar
Sciamanna, G, Bonsi, P, Tassone, A, et al. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiol Dis 2009; 34: 133–145.CrossRefGoogle Scholar
Sharma, N, Baxter, MG, Petravicz, J, et al. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J Neurosci 2005; 25: 5351–5355.CrossRefGoogle ScholarPubMed
Shashidharan, P, Sandu, D, Potla, U, et al. Transgenic mouse model of early-onset DYT1 dystonia. Hum Mol Genet 2005; 14: 125–133.CrossRefGoogle ScholarPubMed
Tanabe, LM, Kim, CE, Alagem, N, et al. Primary dystonia: molecules and mechanisms. Nat Rev Neurol 2009; 5: 598–609.CrossRefGoogle ScholarPubMed
Wilson, BK, Hess, EJ. Animal models for dystonia. Mov Disord 2013; 28: 982–989.CrossRefGoogle ScholarPubMed
Yokoi, F, Dang, MT, Li, J, et al. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J Biochem 2006; 140: 141–146.Google Scholar
Yokoi, F, Dang, MT, Li, J, et al. Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice. PLoS One 2011; 6: e24539.Google Scholar